Black Friday: 30 % off year one, annual plans, until 30 Nov.

See plans →
AdjuderaGet started

Supplier

GE HEALTHCARE BIO-SCIENCES, SAU

Madrid · ESP

Track this recordWith Adjudera Pro, get alerted before a contract here runs out.

Awards

9

Total awarded

€2.0m

9 / 9 with a value

Buyers

3

Sectors

1

Group: GE Healthcare GmbH(inferred)

Reg. A59432179

Contracts this supplier holds that are running out

All expiring contracts →

Awards

AwardedBuyerWinnerContract valuePublished
OMNIPAQUE 300 MG I/ML INYECTABLE 500 ML FRASCO C/6HOSPITAL CLINICO SAN CARLOSGE HEALTHCARE BIO-SCIENCES, SAU€831,60022 Oct 2026
OMNIPAQUE 300 MG I/ML INYECTABLE 50 ML FRASCO C/10HOSPITAL CLINICO SAN CARLOSGE HEALTHCARE BIO-SCIENCES, SAU€2,97022 Oct 2026
VISIPAQUE 320 MG I/ML INYECTABLE 100 ML FRASCO C/10HOSPITAL CLINICO SAN CARLOSGE HEALTHCARE BIO-SCIENCES, SAU€136,85822 Oct 2026
OMNIPAQUE 300 MG I/ML INYECTABLE 100 ML FRASCO C/10HOSPITAL CLINICO SAN CARLOSGE HEALTHCARE BIO-SCIENCES, SAU€59,40022 Oct 2026
OMNIPAQUE 240 MG I/ML INYECTABLE 50 ML FRASCO C/10HOSPITAL CLINICO SAN CARLOSGE HEALTHCARE BIO-SCIENCES, SAU€3,96022 Oct 2026
VISIPAQUE 270 MG I/ML INYECTABLE 100 ML FRASCO C/10HOSPITAL CLINICO SAN CARLOSGE HEALTHCARE BIO-SCIENCES, SAU€76,98222 Oct 2026
Iodixanol 320 65.2% 500ml Vial parentDirección del Servicio Canario de SaludGE HEALTHCARE BIO-SCIENCES, SAU€768,0004 Jul 2025
Iodixanol 320 65.2% 50ml Vial parentDirección del Servicio Canario de SaludGE HEALTHCARE BIO-SCIENCES, SAU€21,1204 Jul 2025
El objeto del contrato viene determinado por el suministro del principio activo denominado "IODIXANOL 320MG 100ML INYECTABLE IV".Dirección Gerencia Hospital Universitario de Gran Canaria Doctor NegrínGE HEALTHCARE BIO-SCIENCES, SAU€70,0803 Apr 2025